Guj. Terce Labs.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE499G01013
NSEID:
BSEID: 524314
View on BSE

INR

36.00

-2.5 (-6.49%)

BSENSE

Mar 24

BSE+NSE Vol: 10.18 k

{
  "main_header": {
    "sid": 890385,
    "name": "Guj. Terce Labs.",
    "stock_name": "Guj. Terce Labs.",
    "full_name": "Gujarat Terce Laboratories Ltd",
    "name_url": "stocks-analysis/guj-terce-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "36.00",
    "chg": -2.5,
    "chgp": "-6.49%",
    "dir": -1,
    "prev_price": "38.50",
    "mcapval": "29.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524314,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE499G01013",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "10.18 k",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/guj-terce-labs-890385-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-falls-to-52-week-low-of-rs3506-3910892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3910892.png",
        "date": "2026-03-24 15:48:53",
        "description": ""
      },
      {
        "title": "Gujarat Terce Laboratories Ltd Hits 52-Week Low Amidst Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-hits-52-week-low-amidst-weak-financial-metrics-3898519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GujaratTerceLab_priceRelatedfactors_3898519.png",
        "date": "2026-03-18 10:00:27",
        "description": "Gujarat Terce Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.36.06 today, marking a significant downturn amid ongoing market pressures and company-specific factors. This new low reflects a continuation of the stock’s underperformance relative to the broader market and its sector peers."
      },
      {
        "title": "Gujarat Terce Laboratories Falls 3.80%: Margin Pressures and Flat Quarterly Results Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-falls-380-margin-pressures-and-flat-quarterly-results-weigh-3826250",
        "imagepath": "",
        "date": "2026-02-07 14:07:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens at ₹44.32, declines 3.65% amid broader market weakness</p>\n                    <p><strong>3 Feb:</strong> Minor decline of 0.65% despite Sensex rallying 2.63%</p>\n                    <p><strong>4 Feb:</strong> Stock rebounds 2.29% following Q3 results revealing profitability collapse</p>\n                    <p><strong>5 Feb:</strong> Sharp 5.40% drop on flat quarterly performance and margin pressure news</p>\n                    <p><strong>6 Feb:</strong> Recovery of 3.85% on low volume, closing at ₹44.25</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Gujarat Terce Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-terce-laboratories-ltd-is-rated-strong-sell-3825718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratTerceLab_mojoScore_3825718.png",
        "date": "2026-02-07 10:10:32",
        "description": "Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Gujarat Terce Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-gujarat-terce-laboratories-ltd-latest-results-good-or-bad-3822903",
        "imagepath": "",
        "date": "2026-02-05 19:26:49",
        "description": "Gujarat Terce Laboratories Ltd's latest financial results indicate significant operational challenges, particularly marked by margin compression and inconsistent profitability. In the quarter ended December 2025, the company reported a net sales decline of 4.95% compared to the previous quarter, which contrasts with a growth of 19.17% in September 2025. This decline in sales is concerning, especially as it follows a period of notable revenue fluctuations.\n\nThe standalone net profit for the December quarter also reflected a substantial decrease of 45.71% compared to the previous quarter, where there was an extraordinary increase of 3,600.00%. This sharp decline raises questions about the sustainability of profitability and operational efficiency. The operating profit margin, which fell to 9.28%, represents a decrease of 5.41% from the prior quarter, further highlighting the challenges in managing costs effec..."
      },
      {
        "title": "Gujarat Terce Laboratories Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-terce-laboratories-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3821519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratTerceLab_fintrenddot_3821519.png",
        "date": "2026-02-05 08:00:24",
        "description": "Gujarat Terce Laboratories Ltd has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, reflecting challenges in sustaining revenue growth and margin expansion in a competitive pharmaceutical sector."
      },
      {
        "title": "Gujarat Terce Laboratories Q3 FY26: Profitability Collapse Raises Serious Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/gujarat-terce-laboratories-q3-fy26-profitability-collapse-raises-serious-concerns-3821123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/GujaratTerceLab_quaterlyResult_3821123.png",
        "date": "2026-02-04 19:17:29",
        "description": "Gujarat Terce Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, has reported deeply concerning quarterly results that highlight mounting operational challenges. The company's net profit collapsed by 71.88% quarter-on-quarter in Q2 FY26 to ₹0.45 crores, whilst posting a modest year-on-year improvement of 21.62%. The stock, trading at ₹46.34, has plunged 43.76% over the past year, significantly underperforming both the Sensex and the broader pharmaceuticals sector."
      },
      {
        "title": "Gujarat Terce Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-terce-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3795471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GujaratTerceLab_mojoScore_3795471.png",
        "date": "2026-01-20 08:21:13",
        "description": "Gujarat Terce Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026, reflecting deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite some recent positive financial results and rising promoter confidence."
      },
      {
        "title": "Gujarat Terce Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-terce-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3791473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GujaratTerceLab_mojoScore_3791473.png",
        "date": "2026-01-14 08:12:14",
        "description": "Gujarat Terce Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators from mildly bearish to sideways, signalling a potential stabilisation in price action. However, the company’s fundamental challenges, including weak long-term growth and expensive valuation metrics, continue to weigh on investor sentiment."
      }
    ],
    "total": 179,
    "sid": "890385",
    "stock_news_url": "https://www.marketsmojo.com/news/gujarat-terce-laboratories-890385"
  },
  "announcements": [
    {
      "caption": "Intimation Of Trading Approval For 371000 Equity Shares Of Face Value Rs. 10/- Each Allotted Pursuant To Conversion Of Warrants Issued On Preferential Basis From BSE Limited",
      "datetime": "24-Feb-2026",
      "details": "Detailed disclosure attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-Feb-2026",
      "details": "Detailed disclosure as attached.",
      "source": "BSE"
    },
    {
      "caption": "Change Of Name Of CompanyS Statutory Auditor",
      "datetime": "04-Feb-2026",
      "details": "This is to inform that the name of the Companys Statutory Auditor M.A. Shah & Co. has been changed to Shah Doshi Patel & Associates LLP.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 15:48:53

Read full news article

Gujarat Terce Laboratories Ltd Hits 52-Week Low Amidst Weak Financial Metrics

2026-03-18 10:00:27

Gujarat Terce Laboratories Ltd’s share price declined to a fresh 52-week low of Rs.36.06 today, marking a significant downturn amid ongoing market pressures and company-specific factors. This new low reflects a continuation of the stock’s underperformance relative to the broader market and its sector peers.

Read full news article

Gujarat Terce Laboratories Falls 3.80%: Margin Pressures and Flat Quarterly Results Weigh

2026-02-07 14:07:36

Key Events This Week

2 Feb: Stock opens at ₹44.32, declines 3.65% amid broader market weakness

3 Feb: Minor decline of 0.65% despite Sensex rallying 2.63%

4 Feb: Stock rebounds 2.29% following Q3 results revealing profitability collapse

5 Feb: Sharp 5.40% drop on flat quarterly performance and margin pressure news

6 Feb: Recovery of 3.85% on low volume, closing at ₹44.25

Week Open

<...

Read full news article

Gujarat Terce Laboratories Ltd is Rated Strong Sell

2026-02-07 10:10:32

Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Gujarat Terce Laboratories Ltd latest results good or bad?

2026-02-05 19:26:49

Gujarat Terce Laboratories Ltd's latest financial results indicate significant operational challenges, particularly marked by margin compression and inconsistent profitability. In the quarter ended December 2025, the company reported a net sales decline of 4.95% compared to the previous quarter, which contrasts with a growth of 19.17% in September 2025. This decline in sales is concerning, especially as it follows a period of notable revenue fluctuations. The standalone net profit for the December quarter also reflected a substantial decrease of 45.71% compared to the previous quarter, where there was an extraordinary increase of 3,600.00%. This sharp decline raises questions about the sustainability of profitability and operational efficiency. The operating profit margin, which fell to 9.28%, represents a decrease of 5.41% from the prior quarter, further highlighting the challenges in managing costs effec...

Read full news article

Gujarat Terce Laboratories Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-02-05 08:00:24

Gujarat Terce Laboratories Ltd has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, reflecting challenges in sustaining revenue growth and margin expansion in a competitive pharmaceutical sector.

Read full news article

Gujarat Terce Laboratories Q3 FY26: Profitability Collapse Raises Serious Concerns

2026-02-04 19:17:29

Gujarat Terce Laboratories Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹33.00 crores, has reported deeply concerning quarterly results that highlight mounting operational challenges. The company's net profit collapsed by 71.88% quarter-on-quarter in Q2 FY26 to ₹0.45 crores, whilst posting a modest year-on-year improvement of 21.62%. The stock, trading at ₹46.34, has plunged 43.76% over the past year, significantly underperforming both the Sensex and the broader pharmaceuticals sector.

Read full news article

Gujarat Terce Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-01-20 08:21:13

Gujarat Terce Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026, reflecting deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite some recent positive financial results and rising promoter confidence.

Read full news article

Gujarat Terce Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-01-14 08:12:14

Gujarat Terce Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators from mildly bearish to sideways, signalling a potential stabilisation in price action. However, the company’s fundamental challenges, including weak long-term growth and expensive valuation metrics, continue to weigh on investor sentiment.